High-Quality, Low-Dose CTA Imaging

We are at an inflection point with many aspects of medicine, not the least of which concerns choosing the correct tool to discover and manage coronary artery disease. The American landscape of clinical and imaging service providers is going through a major reshuffle. Coronary computed tomography angiography (CTA) is growing in utilization, taking its place as an established modality with AHA-, ACC- and ACR society-derived appropriate use standards. However, this growth in CT utilization and the resultant growth in per capita radiation exposure have elevated a very public debate about the risk of causing cancer versus the value of its information content.
The Philips Ingenuity TF PET/MR system
Siemens Biograph mMR PET/MR system
whole body image

The new imaging modality of positron emission tomography (PET)/magnetic resonance imaging (MRI) was introduced in the U.S. market last summer. The Siemens Biograph mMR (molecular MR) gained U.S. Food and Drug Administration (FDA) 510(k) clearance as the first dedicated PET/MRI system. It is the only system to combine both modalities into one machine, allowing simultaneous imaging of location, function and metabolic activity of organs in a single image.

 

November 23, 2011 – The University of Alabama at Birmingham (UAB) Health System became the first medical center in the world last week to utilize intrafraction motion review (IMR), or "triggered imaging," to continually monitor tumor location during radiosurgery for lung cancer.  IMR, which is a unique capability of the TrueBeam linear accelerator from Varian Medical Systems enables visual verification that a tumor is being properly targeted.

 

November 23, 2011  –Varian Medical Systems will exhibit its PaxScan digital image detectors and new PaxPower X-ray tubes at the MEDICA 2011 International Trade Fair in Dusseldorf, Germany from November 16-19, 2011.

Canadian Task Force Recommends Against Breast Cancer Screening for Women Under 50

November 21, 2011 — The Canadian Task Force on Preventive Health Care has released an updated guideline for breast cancer screening in average-risk women aged 40 to 74, published in the Canadian Medical Association Journal. The new guideline, which weighs the potential harms of false positives and unnecessary biopsies against the potential benefits of breast cancer screening in average risk women, updates prior guidelines by the Task Force from 1994 and 2001 and recommends against routine screening for women under age 50.

November 3, 2011 — Infinitt North America announced that their Xelis Cardiac product has received clearance from the U.S. Food and Drug Administration, and is now widely available to the North American market.

Centura Health is the largest healthcare network in Colorado. Dedicated to delivering advanced care to more than a half million people, Centura strives for the highest quality and continuous innovation. To accomplish this, the organization needed to address its transformation and connectivity efforts across patient, people, processes and technologies — the essential ingredients when optimizing clinical performance. Centura understands that by mastering clinical image data across its care network it will enable clinical improvements, optimize electronic medical record (EMR) investments and drive the organization’s interoperability strategy. Centura had several key requirements necessary to adequately consider a VNA solution.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now